Hoosier Cancer Research Network

Happy 12th Hoosier Cancer Research Network anniversary to Mayan Howard! Mayan is a key player in our correlative research efforts, serving as a resource for our biorepository facilities and processes. She expertly oversees sample management, maintains equipment, and ensures quality control to uphold the integrity of our research. Mayan also creates collection kits and provides training to research sites, helping them follow best laboratory practices for HCRN trials. Mayan, your dedication and expertise make a meaningful impact on our work. Thank you for everything you do!

Happy 5th Hoosier Cancer Research Network anniversary to Brian Kostoff! ? Brian plays a vital role in our research efforts, supporting principal investigators with all clinical correlative aspects of their trials. From ensuring the timely and accurate collection of samples to writing study procedure manuals, Brian makes sure our sample management processes are precise and efficient. His guidance supports our research sites in upholding best laboratory practices, ultimately strengthening the quality of our HCRN trials. ? Brian, we appreciate your commitment and expertise—thank you for all that you do!

Researchers participating in the Hoosier Cancer Research Network GU16-260 study have published a correlative analysis in Cancer Discovery. The analysis, led by David Braun, MD, PhD, of Yale Cancer Center; Catherine J. Wu, MD, of the Dana-Farber Cancer Institute; and Michael B. Atkins, MD, of Georgetown Lombardi Comprehensive Cancer Center, found that the presence of tertiary lymphoid structures and exhausted tissue-resident T cells determines clinical response to PD-1 blockade in renal cell carcinoma. Congratulations to all co-authors and study teams whose hard work led to this publication! Read more: https://lnkd.in/gdQi9AsM

A HCRN non-small cell lung cancer study (RAMOSE trial) was published and featured in the February 1, 2025 issue of the Journal of Clinical Oncology. Congratulations to all co-authors and study teams whose hard work led to this publication! Read more: https://lnkd.in/gVC5UTsj

Happy 4th Hoosier Cancer Research Network anniversary to Kelsey Schmutte! ? Kelsey is a critical part of our research efforts, ensuring the quality and completeness of clinical trial data. As clinical data validator, her expertise in data validation and her attention to detail has played a key role in advancing oncology research.? ? Kelsey, thank you for your dedication and hard work—your contributions make a lasting impact!

??? February is #GallbladderCancer and #BileDuctCancer Awareness Month! Our team proudly wore Kelly green to raise awareness! Did you know? ?? About 12,610 new cases are diagnosed in the US every year ?? About 4,400?deaths occur annually from these cancers ?? Only about 1 in 5 gallbladder cancers is found in the early stages, when the cancer has not yet spread outside the gallbladder. How are you raising awareness this month?

Happy 4th Hoosier Cancer Research Network anniversary to Brittany Brugh! ? Brittany is a key player in ensuring the accuracy and integrity of our clinical trial data. From performing data validation, designing databases or site training, Brittany’s expertise shines through in every step of?the process.? ? Thank you, Brittany, for your dedication and hard work!

Congratulations, Dr. Noah Hahn of Johns Hopkins Kimmel Cancer Center and all co-authors on presentation of the ADAPT-BLADDER (HCRN-GU16-243) Cohort 4 results at #GU25.

Congratulations to Dr. Deepak Kilari of Froedtert and the Medical College of Wisconsin and all co-authors on presenting the ABATE study, HCRN-GU18-343! #GU25

Thank you to everyone who attended our GU Working Group meeting. We appreciate your time and contributions to the discussion! #GU25